(firstQuint)Study of HBV-001 D1 in Healthy Adults.

 This is a single-center, double-blind, randomized, Phase 1 study to assess the safety and tolerability of HBV-001 D1 in healthy adult subjects.

 This will be an upward titration of two dose levels of HBV-001 D1 (10 mu g and 50 mu g of DEN1-80E) in 16 subjects across two cohorts.

 Participants in each cohort will receive HBV-001 D1 vaccine or placebo on Visits 1, 3 and 5.

.

 Study of HBV-001 D1 in Healthy Adults@highlight

This is a single-center, double-blind, randomized, Phase 1 study to assess the safety and tolerability of HBV-001 D1 in healthy adult subjects.

